Abstract:Background: It has been reported that oxidation product of cholesterol, 7-ketocholesterol, increases in plasma of patients with NP-C. Previously, we established a rapid test to determine the plasma 7-ketocholesterol level and found it elevated significantly in patients with acid sphingomyelinase deficient NPD and NP-C disease.Methods: Individuals randomly referred to our outpatient clinics in the past two years for hepatosplenomegaly or isolated splenomegaly, who have been excluded as acid sphingomyelinase deficient NPD or Gaucher disease, and individuals with newborn cholestasis, psychomotor regression/retardation, were screened for plasma 7-ketocholesterol level. Individuals with high 7-ketocholesterol level were then analyzed for NPC1 and NPC2 gene mutation to confirm the accuracy of NP-C diagnosis.Results: By screening the plasma 7-ketocholesterol of suspect individuals, 12 out of 302 (4%) had shown remarkable high levels compared with reference. All these twelve individuals were subsequently confirmed to be NP-C by DNA analysis of NPC1 and NPC2 genes, with the early infantile form (n = 7), the late infantile form (n = 1), the juvenile form (n = 1) and the adult form (n = 1). Furthermore, two NP-C patients without observable neuropsychiatric disability were picked up through this procedure. Only one patient had NP-C due to NPC2 gene mutations, with the rest due to NPC1 gene mutations. We found that in NP-C patients AST was usually mildly elevated and ALT was in a normal range when jaundice was not present. In total, 22 mutant alleles were identified in the NPC1 gene, including six novel small deletions/insertions, e. g., c.416_417insC, c.1030delT, c.1800delC, c.2230_2231delGT, c.2302_2303insG, and c.2795dupA; seven novel exonic point mutations, c. 1502A>T (p.D501V), c.1553G>A (p.R518Q), c.1832A>G (p.D611G), c.2054T>C (p.I685T), c.2128C>T(p.Q710X), c.2177G>C (p.R726T), c.2366G>A (p.R789H), and one novel intronic mutation c. 2912-3C>G. Small deletions/insertions constituted nearly half of the mutant alleles (10/22, 45%), indicating a unique mutation spectrum in this cohort of Chinese NP-C patients.Conclusion: Our data confirm in a clinical setting that screening plasma 7-ketocholesterol is an efficient and practical diagnostic tool to identify NP-C patients from suspect individuals. Patients without neuropsychological involvement could also be identified by this method therefore allowing an opportunity for earlier treatment.

Three Chinese children with Niemann-Pick disease type C with neonatal cholestasis as initial presentation

Case Report: Be Aware of “New” Features of Niemann–Pick Disease: Insights From Two Pediatric Cases

Genotype/phenotype of 6 Chinese cases with Niemann-Pick disease type C.

[Genetic Analysis of Newborns with Abnormal Metabolism of 3-Hydroxyisovalerylcarnitine].

Niemann-Pick Disease Type C: Analysis of 7 Patients

Clinical analysis of 4 case of Niemann-Pick disease type C

Diagnosis of Niemann-Pick Disease Type C with 7-Ketocholesterol Screening Followed by NPC1/NPC2 Gene Mutation Confirmation in Chinese Patients

The Presence of Vacuolated Kupffer Cells Raises a Clinical Suspicion of Niemann-Pick Disease Type C in Neonatal Cholestasis

Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency: Clinical and Laboratory Investigation of 13 Subjects in Mainland of China

Neonatal intrahepatic cholestasis caused by citrin deficiency: a clinicopathological analysis of two cases

Prenatal revelation of Niemann-Pick disease type C in siblings

[Blood 7-Ketocholesterol Level, Clinical Features and Gene Mutation Analysis of 18 Children with Niemann-Pick Disease Type C].

Presence of Lipid Vacuoles in Kupffer Cells as a Marker for Early Detection of Niemann-Pick Disease Type C in Neonatal Cholestasis

Clinical research of neonatal intrahepatic cholestasis caused by Citrin deficiency in Hubei Province

Genetic Analysis and Prenatal Diagnosis for a Family with Niemann-Pick Disease Type C

[Analysis of clinical and genetic variation in neonatal intrahepatic cholestasis caused by citrin deficiency]

Clinical and Genetic Analysis of 26 Chinese Patients with Neonatal Intrahepatic Cholestasis Due to Citrin Deficiency.

Rapid whole-genome sequencing identifies a novel homozygous NPC1 variant associated with Niemann–Pick type C1 disease in a 7-week-old male with cholestasis

[Analysis of clinical characteristic of children with progressive familial intrahepatic cholestasis type 3]

Primary carnitine deficiency: Estimation of prevalence in Chinese population and insights into newborn screening

Seven Novel Mutations of the SMPD1 Gene in Four Chinese Patients with Niemann-Pick Disease Type A and Prenatal Diagnosis for Four Fetuses.